Founder and CEO at Insilico Medicine, a leader in next-generation artificial intelligence technologies for drug discovery and biomarker development. He is also the founder of Deep Longevity, Inc, a spin-off of Insilico Medicine developing a broad range of artificial intelligence-based biomarkers of aging and longevity servicing healthcare providers and life insurance industry.
Milan Longevity Summit 2024
Riscrivere il tempo Science and Myths of the Longevity Rush March 14-27, 2024 Is it possible and ethical, to engage in a chase for eternal
